logo

The team

The most expert team of professionals at your service

More than 700 people are working in 6 companies that make up the group MOEHS
(Iberica, Catalana, Cantabra, Coprima, Benechim and Moehs BCN).

Directing and managing the activity of the group is the Steering Committee that promotes conducting internal and external training programs in accordance with strategic objectives of the Company and the specific needs related to the work activity, with special emphasis on Good Manufacturing Practices, Safety and the Environment.

Total employees

name20132014201520162017201820192020202120222023
MOEHS IBERICA S.L899897102117117127138136139141
MOEHS CATALANA S.L211205223218227222222229218219217
MOEHS CANTABRA S.L140143161156173160155168179167161
MOEHS COPRIMA7374737478849392878891
BENECHIM6262717064676867646569
MOEHS BCN1037454751566168759796
TOTAL585619670667710706726762759775775

The current organization of the Moehs Group is:

MOEHS IBERICA, S.L.

Company that houses the Management Committee and all common services manufacturing plants. Located in Rubí (Barcelona), Spain.

MOEHS CATALANA, S.L

Production plant located in Rubí (Barcelona), Spain.

MOEHS CANTABRA, S.L

Production plant located in Polanco (Cantabria), Spain.

COPRIMA, S.L.

Production plant located in Polinyà (Barcelona), Spain.

BENECHIM S.p.r.l.

Production plant located in Lessiness, Belgium.

MOEHS BCN, S.L.

Production plant located in Castellbisbal (Barcelona), Spain.

MOEHS GROUP RESEARCH CENTER

Group Investigation center located in Rubí (Barcelona), Spain.

All the production centers are interconnected, guaranteeing the perfect operation of the MOEHS group. Our manufacturing plants work 24/7.

logo
Twitter Linkedin-in
  • Headquarters:
  • Pol. Ind. Cova Solera
  • c/Roma, 8-12 08191 Rubí.
  • Barcelona (Spain)
  • T +34 93 586 05 20
  • Fax +34 93 588 85 13
  • info@moehs.es

Partnering companies

The Board of Directors of the Center for Technological Development and Innovation, E.P.E (CDTI), in its meeting held on 02/23/2023, approved the participation of this center in the research and development project called SYNTHESIS OF A STIMULATOR ACTIVE PRINCIPLE OF SOLUBLE CYCLASE GUANYLATE by granting partially reimbursable aid.

The objective is focused on the development of a new method of chemical synthesis of an active ingredient that stimulates soluble guanylate cyclase.

The project will be carried out at the Rubí facilities. The project execution period is from 2022 to 2024 and they have a financeable budget of €1,862,213.00.
This project is co-financed by the European Union and CDTI.

The Board of Directors of the Center for Technological Development and Innovation, E.P.E (CDTI), in its meeting held on 02/23/2023, approved the participation of this center in the research and development project called SYNTHESIS OF AN ACTIVE INHIBITOR PRINCIPLE OF JANUS KINASE FOR THE TREATMENT OF ATOPIC DERMATITIS.”, by granting partially reimbursable aid.

The objective is focused on the development of a new method of chemical synthesis of a janus kinase inhibitor active ingredient for the treatment of atopic dermatitis.

The project will be carried out at the Rubí facilities. The project execution period is from 2022 to 2025 and they have a financeable budget of €1,940,409.
This project is co-financed by the European Union and CDTI.